サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1301133

耐久医療機器の市場規模、シェア、動向分析レポート：製品別（パーソナルモビリティデバイス、モニタリング・治療デバイス）、最終用途別（病院、介護施設）、地域別、セグメント予測、2023年～2030年

Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product (Personal Mobility Devices, Monitoring And Therapeutic Devices), By End Use (Hospitals, Nursing Homes), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
耐久医療機器の市場規模、シェア、動向分析レポート：製品別（パーソナルモビリティデバイス、モニタリング・治療デバイス）、最終用途別（病院、介護施設）、地域別、セグメント予測、2023年～2030年
出版日: 2023年06月23日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

耐久医療機器市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の耐久医療機器市場規模は3,311億米ドルに達し、2023年から2030年にかけてCAGR 5.9％を記録すると予測されています。

同市場は主に、腎不全やがんなどの慢性疾患の増加によって牽引されています。さらに、技術の進歩と強力な償還シナリオが、予測期間中に耐久医療機器（DME）市場を押し上げる可能性が高いです。

世界中で老年人口が増加していることも、業界の拡大に寄与しています。60歳以上の高齢者は、糖尿病、運動障害、心血管疾患（CVDs）、その他の生活習慣病などの健康問題を抱えやすいです。これがDME製品に対する需要を生み出しています。しかし、新興経済諸国では規制ガイドラインが厳しく、熟練した専門家の不足が市場の成長を制限する可能性があります。

COVID-19パンデミックは当初、製品の供給不足により市場に影響を与えました。市場関係者はパンデミックの間、業務、売上、収益の減少を招いた。パンデミックの発生は、政府による規制により、顧客の消費習慣を一時的に変化させました。パンデミックは、市場関係者が被った金銭的損失を回復するための製品および販売後のサービスのコスト上昇をもたらしました。

技術的に進歩した製品の入手可能性も、市場の成長にプラスの影響を与える重要な役割を果たしています。米国、英国、ドイツなどの国々は、先進技術の革新者であり、いち早く導入した国であるため、急速な技術革新が進む医療機器市場にとって最も重要な顧客です。予測期間中、効率を高めることに集中した技術的ブレークスルーが起こると予想され、それによって市場成長が促進されます。

耐久医療機器市場レポートハイライト

  • モニタリングおよび治療用機器は、より快適で携帯性に優れた技術的に先進的な製品の発売により、最大セグメントとして浮上しました。
  • 在宅ヘルスケアは、安価で高齢者に好まれることから、予測期間中に最も急成長する分野と予想されます。
  • 北米は2022年に最大のシェアを獲得して市場をリードしており、同地域には大手企業が進出していることから、今後も着実な成長が見込まれます。
  • アジア太平洋地域は、対象人口が多く、ヘルスケア施設が充実していることから、予測期間中に最も高いCAGRを記録すると予想されます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 製品
    • インプラントの形状
    • 応用
    • 最終用途
    • 対象国の範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー解析（モデル1）
    • 数量価格分析（モデル2）
  • 二次情報のリスト
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合のスナップショット

第3章 DME市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • DME市場分析ツール
    • 業界分析- ポーターズ
    • PESTEL分析
    • 主要取引と戦略的提携の分析

第4章 DME市場：製品の推定・動向分析

  • 製品市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 製品別の世界のDME市場の見通し
    • パーソナルモビリティデバイス
    • 浴室用安全装置および医療用家具
    • モニタリングおよび治療装置

第5章 DME市場：最終用途の推定・動向分析別

  • 最終用途市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界のDME市場の見通し
    • 病院
    • 介護施設
    • 在宅ヘルスケア
    • その他

第6章 DME市場：地域の推定・動向分析

  • 地域市場シェア分析、2022年および2030年
  • 国別市場のダッシュボード
  • 地域市場のスナップショット
  • 地域市場シェアと主要企業、2022年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場規模、予測、量および傾向分析、2018年から2030年：
  • 北米
    • 市場推計・予測、2018～2030年（100万米ドル）
    • 米国
    • カナダ
  • 欧州
    • 市場推計・予測、2018～2030年（100万米ドル）
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 市場推計・予測、2018～2030年（100万米ドル）
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • 市場推計・予測、2018～2030年（100万米ドル）
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 市場推計・予測、2018～2030年（100万米ドル）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2022
    • Invacare Corporation
    • Arjohuntleigh
    • Stryker Corporation
    • Hill Rom, Inc.
    • Drive Medical
    • GF Health Products, Inc.
    • Sunrise Medical
    • Medline Industries, Inc.
    • Carex Health Brands, Inc.
    • Becton, Dickinson &Company
    • General Electric Company
    • Medtronic PLC
    • Compass Health Brands
    • Getinge AB
    • Resmed, Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America DME Market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America DME Market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S DME Market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada DME Market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe DME Market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe DME Market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 UK DME Market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK DME Market, by end-use, (USD million) 2018 - 2030
  • Table 14 Germany DME Market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Italy DME Market, by product, 2018 - 2030 (USD Million)
  • Table 17 Italy DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 France DME Market, by product, 2018 - 2030 (USD Million)
  • Table 19 France DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain DME Market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark DME Market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden DME Market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden DME Market, by end-use, (USD million) 2018 - 2030
  • Table 26 Norway DME Market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific DME Market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific DME Market, by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Japan DME Market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China DME Market, by product, 2018 - 2030 (USD Million)
  • Table 34 China DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India DME Market, by product, 2018 - 2030 (USD Million)
  • Table 36 India DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia DME Market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia DME Market, by end-use, (USD million) 2018 - 2030
  • Table 39 South Korea DME Market, by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand DME Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Thailand DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America DME Market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America DME Market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil DME Market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico DME Market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina DME Market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA DME Market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA DME Market, by product, 2018 - 2030 (USD Million)
  • Table 54 MEA DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa DME Market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia DME Market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE DME Market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE DME Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait DME Market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait DME Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 DME market: market outlook
  • Fig. 14 DME market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 DME market driver impact
  • Fig. 19 DME market restraint impact
  • Fig. 20 DME market strategic initiatives analysis
  • Fig. 21 DME market: product movement analysis
  • Fig. 22 DME market: product outlook and key takeaways
  • Fig. 23 Personal mobility devices market estimates and forecast, 2018 - 2030
  • Fig. 24 Wheelchairs market estimates and forecast, 2018 - 2030
  • Fig. 25 Scooters market estimates and forecast, 2018 - 2030
  • Fig. 26 Walkers & Rollators market estimates and forecast, 2018 - 2030
  • Fig. 27 Cranes & Crutches market estimates and forecast, 2018 - 2030
  • Fig. 28 Door Openers market estimates and forecast, 2018 - 2030
  • Fig. 29 Others market estimates and forecast, 2018 - 2030
  • Fig. 30 Bathroom Safety Devices & Hospital Furniture market estimates and forecast, 2018 - 2030
  • Fig. 31 Commodes & Toilets market estimates and forecast, 2018 - 2030
  • Fig. 32 Mattresses & Bedding Devices market estimates and forecast, 2018 - 2030
  • Fig. 33 Monitoring & Therapeutic Devices market estimates and forecast, 2018 - 2030
  • Fig. 34 Blood Glucose Monitors market estimates and forecast, 2018 - 2030
  • Fig. 35 CPM Therapy market estimates and forecast, 2018 - 2030
  • Fig. 36 Suction Pumps market estimates and forecast, 2018 - 2030
  • Fig. 37 Traction Equipment market estimates and forecast, 2018 - 2030
  • Fig. 38 Other Equipment market estimates and forecast, 2018 - 2030
  • Fig. 39 DME market: End-use outlook and key takeaways
  • Fig. 40 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 41 Nursing Homes market estimates and forecast, 2018 - 2030
  • Fig. 42 Home healthcare market estimates and forecast, 2018 - 2030
  • Fig. 43 Others market estimates and forecast, 2018 - 2030
  • Fig. 44 Global DME market: Regional movement analysis
  • Fig. 45 Global DME market: Regional outlook and key takeaways
  • Fig. 46 Global market shares and leading players
  • Fig. 47 North America market share and leading players
  • Fig. 48 Europe market share and leading players
  • Fig. 49 Asia Pacific market share and leading players
  • Fig. 50 Latin America market share and leading players
  • Fig. 51 Middle East & Africa market share and leading players
  • Fig. 52 North America: SWOT
  • Fig. 53 Europe SWOT
  • Fig. 54 Asia Pacific SWOT
  • Fig. 55 Latin America SWOT
  • Fig. 56 MEA SWOT
  • Fig. 57 North America, by country
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecast, 2018 - 2030
  • Fig. 60 U.S.
  • Fig. 61 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 62 Canada
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 66 U.K.
  • Fig. 67 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 68 Germany
  • Fig. 69 Germany market estimates and forecast, 2018 - 2030
  • Fig. 70 France
  • Fig. 71 France market estimates and forecast, 2018 - 2030
  • Fig. 72 Italy
  • Fig. 73 Italy market estimates and forecast, 2018 - 2030
  • Fig. 74 Spain
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030
  • Fig. 76 Denmark
  • Fig. 77 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 78 Sweden
  • Fig. 79 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 80 Norway
  • Fig. 81 Norway market estimates and forecast, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030
  • Fig. 86 China
  • Fig. 87 China market estimates and forecast, 2018 - 2030
  • Fig. 88 India
  • Fig. 89 India market estimates and forecast, 2018 - 2030
  • Fig. 90 Australia
  • Fig. 91 Australia market estimates and forecast, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 94 South Korea
  • Fig. 95 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 98 Brazil
  • Fig. 99 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 100 Mexico
  • Fig. 101 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 102 Argentina
  • Fig. 103 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 104 Middle East and Africa
  • Fig. 105 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 106 Saudi Arabia
  • Fig. 107 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 110 UAE
  • Fig. 111 UAE market estimates and forecast, 2018 - 2030
  • Fig. 112 Kuwait
  • Fig. 113 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 114 Participant categorization - DME market
  • Fig. 115 Market share of key market players - DME market
目次
Product Code: GVR-1-68038-084-2

Durable Medical Equipment Market Growth & Trends

The global durable medical equipment market size is expected to reach USD 331.1 billion and register a CAGR of 5.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by a rise in chronic diseases, such as kidney failure and cancer. Moreover, technological advancements along with a strong reimbursement scenario are likely to boost the durable medical equipment (DME) market over the forecast period.

The growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and a lack of skilled professionals may limit the market growth.

The COVID-19 pandemic has initially affected the market due to the shortage of supply of the product. The market players have resulted in a decline in operations, sales, and revenue during the pandemic. The outbreak has temporarily changed the customer's spending habits due to the restrictions imposed by the government. The pandemic has resulted in rising costs of the product and post-sale services for the recovery of financial loss incurred by the market players.

The availability of technologically advanced products has also played an important role in positively impacting the growth of the market. Countries such as U.S., UK, and Germany are innovators and early adopters of advanced technologies, thus these are the most important customers for medical device markets with rapid technological innovations. Technological breakthroughs concentrating on increasing efficiency are expected to occur during the forecast period, thereby driving market growth.

Durable Medical Equipment Market Report Highlights

  • Monitoring and therapeutic devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability.
  • Home healthcare is anticipated to be the fastest-growing segment in the forecast period as it is less expensive and preferred by aged people.
  • North America led the market with the largest share in 2022 and will witness steady growth in the future on account of the presence of major companies in the region.
  • Asia Pacific is expected to register the highest CAGR in the forecast period owing to the presence of a large target population base and improving healthcare facilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Implant Shape
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Country scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Snapshot

Chapter 3. DME Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. DME Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major deals & strategic alliances analysis

Chapter 4. DME Market by Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2022 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global DME Market by Product Outlook
    • 4.3.1. Personal Mobility Devices
      • 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.2. Wheelchairs
      • 4.3.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.3. Scooters
      • 4.3.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.4. Walkers & Rollators
      • 4.3.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.5. Cranes & Crutches
      • 4.3.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.6. Door Openers
      • 4.3.1.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.1.7. Other Devices
      • 4.3.1.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.3.2. Bathroom Safety Devices & Medical Furniture
      • 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.2.2. Commodes & Toilets
      • 4.3.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.2.3. Mattress & Bedding Devices
      • 4.3.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.3.3. Monitoring & Therapeutic Devices
      • 4.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.2. Blood Glucose Monitors
      • 4.3.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.3. Continuous Passive Motion Therapy
      • 4.3.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.4. Infusion Pumps
      • 4.3.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.5. Nebulizers
      • 4.3.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.6. Oxygen Equipment
      • 4.3.3.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.7. CPAP
      • 4.3.3.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.8. Suction Pump
      • 4.3.3.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.9. Traction Equipment
      • 4.3.3.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.3.3.10. Other Equipment
      • 4.3.3.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. DME Market: By End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2022 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global DME Market by End-use Outlook
    • 5.3.1. Hospitals
      • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2. Nursing Homes
      • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Home Healthcare
      • 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. DME Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. County Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2022
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. U.S.
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Structure/Reimbursement Scenario
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. Canada
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Structure/Reimbursement Scenario
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.2. U.K.
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.3. Germany
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.4. France
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.5. Italy
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.5.3. Competitive Scenario
      • 6.8.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.6. Spain
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.6.3. Competitive Scenario
      • 6.8.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.7. Denmark
      • 6.8.7.1. Key Country Dynamics
      • 6.8.7.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.7.3. Competitive Scenario
      • 6.8.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.8. Sweden
      • 6.8.8.1. Key Country Dynamics
      • 6.8.8.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.8.3. Competitive Scenario
      • 6.8.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.8.9. Norway
      • 6.8.9.1. Key Country Dynamics
      • 6.8.9.2. Regulatory Structure/Reimbursement Scenario
      • 6.8.9.3. Competitive Scenario
      • 6.8.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.2. Japan
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.3. China
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.4. India
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.5. Australia
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.5.3. Competitive Scenario
      • 6.9.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.6. South Korea
      • 6.9.6.1. Key Country Dynamics
      • 6.9.6.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.6.3. Competitive Scenario
      • 6.9.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.9.7. Thailand
      • 6.9.7.1. Key Country Dynamics
      • 6.9.7.2. Regulatory Structure/Reimbursement Scenario
      • 6.9.7.3. Competitive Scenario
      • 6.9.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.10. Latin America
    • 6.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.10.2. Brazil
      • 6.10.2.1. Key Country Dynamics
      • 6.10.2.2. Regulatory Structure/Reimbursement Scenario
      • 6.10.2.3. Competitive Scenario
      • 6.10.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.10.3. Mexico
      • 6.10.3.1. Key Country Dynamics
      • 6.10.3.2. Regulatory Structure/Reimbursement Scenario
      • 6.10.3.3. Competitive Scenario
      • 6.10.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.10.4. Argentina
      • 6.10.4.1. Key Country Dynamics
      • 6.10.4.2. Regulatory Structure/Reimbursement Scenario
      • 6.10.4.3. Competitive Scenario
      • 6.10.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.11. Middle East & Africa
    • 6.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.11.2. South Africa
      • 6.11.2.1. Key Country Dynamics
      • 6.11.2.2. Regulatory Structure/Reimbursement Scenario
      • 6.11.2.3. Competitive Scenario
      • 6.11.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.11.3. Saudi Arabia
      • 6.11.3.1. Key Country Dynamics
      • 6.11.3.2. Regulatory Structure/Reimbursement Scenario
      • 6.11.3.3. Competitive Scenario
      • 6.11.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.11.4. UAE
      • 6.11.4.1. Key Country Dynamics
      • 6.11.4.2. Regulatory Structure/Reimbursement Scenario
      • 6.11.4.3. Competitive Scenario
      • 6.11.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.11.5. Kuwait
      • 6.11.5.1. Key Country Dynamics
      • 6.11.5.2. Regulatory Structure/Reimbursement Scenario
      • 6.11.5.3. Competitive Scenario
      • 6.11.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. Invacare Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Procedure benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Arjohuntleigh
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Procedure benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Stryker Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Procedure benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Hill Rom, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Procedure benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Drive Medical
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Procedure benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. GF Health Products, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Procedure benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Sunrise Medical
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Procedure benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Medline Industries, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Procedure benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Carex Health Brands, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Procedure benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Becton, Dickinson & Company
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Procedure benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. General Electric Company
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Procedure benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Medtronic PLC
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Procedure benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Compass Health Brands
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Procedure benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Getinge AB
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Procedure benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. Resmed, Inc.
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Procedure benchmarking
      • 7.3.18.4. Strategic initiatives